USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name: BIOFORMATIX, INC.
City: SAN DIEGO
State: CA
Zip+4: 92128-3786
Woman-Owned: Yes
Minority-Owned: No
HUBZone-Owned: No
Website URL: N/A
Phone: N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $599,981.00 2
SBIR Phase II $1,488,230.00 2

Award List:

Diagnostic aid software for the visual field test

Award Year / Program / Phase: 2005 / SBIR / Phase II
Agency: HHS
Principal Investigator: Dariusz Wroblewski
Award Amount: $631,973.00
Abstract:
Visual field (VF) test is a widely used, noninvasive technique for evaluating pathology or dysfunction in the visual pathways. The VF test, in conjunction with other diagnostics, is used for detection of laucoma and for following its progression. Early detection is critical as blindness from… More

Head mounted display apparatus for visual field test

Award Year / Program / Phase: 2008 / SBIR / Phase II
Agency: HHS
Principal Investigator:
Award Amount: $856,257.00
Abstract:
DESCRIPTION (provided by applicant): The goal of this Phase II SBIR project is to design, develop, test and demonstrate clinical use of a lightweight, low cost, head mounted perimeter (apparatus for visual field test). The HMDField device integrates commer cial off-the-shelf hardware components… More

Computational framework for analysis of microarray gene expression data

Award Year / Program / Phase: 2009 / SBIR / Phase I
Agency: HHS
Principal Investigator: Dariusz Wroblewski
Award Amount: $299,983.00
Abstract:
DESCRIPTION (provided by applicant): Identification of transcripts that are differentially regulated in response to studied experimental conditions is one of critical steps in analysis of DNA microarray data. Currently employed statistical approaches becom e particularly ineffective for experiments… More

Utrasensitive bioassays using palladium catalyzed chemical amplification

Award Year / Program / Phase: 2011 / SBIR / Phase I
Agency: HHS
Principal Investigator: Mark Lelental – 858-248-2885
Award Amount: $299,998.00
Abstract:
DESCRIPTION (provided by applicant): We propose to use novel Palladium Catalyzed Chemical Amplification (PdCCA) technology to develop ultra-sensitive bioassays that can detect very low concentrations of tumor biomarkers in blood. PdCCA is a generic technology that can be universally applied to… More